PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Other: PET Scan
- Registration Number
- NCT01320852
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Brief Summary
This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Male or female patient over 18 years of age
- Diagnosis of HCC confirmed by histology if available or by two imaging modalities
- Able to give written informed consent prior to any study specific screening procedures with the understanding that the patient has the right to withdraw from the study at any time, without prejudice.
Exclusion Criteria
- Unable to give consent to the study
- Unable to undergo a PET Scan
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description No Milan Criteria PET Scan Patients not meeting the Milan Criteria Milan Criteria PET Scan Patients meeting the Milan Criteria
- Primary Outcome Measures
Name Time Method Overall Survival up to death The primary objective of the study is to compare, according to PET scan results, the post-transplantation overall survival of patients meeting Milan criteria to those not meeting Milan criteria
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
McGill Univeristy Health Centre
🇨🇦Montreal, Quebec, Canada